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The article by Zhu et al. (1) publishedinDiabetes Care concludes that a fast-ing plasma glucose (FPG) at 24–28
weeks’ gestation can be used in low-
resource regions as a screening test to
identify gestational diabetes mellitus
(GDM) in Chinese patients. However,
in their experience, a screening proto-
col using FPG cutoff points of $4.4
and #5.0 mmol/L would fail to identify
about 12% of the GDM cases and
require a formal oral glucose tolerance
test (OGTT) to be performed in about
half of the pregnant population (1).
These observations contrast with our
ﬁndings in a circum-Mediterranean
population (2). In our population, a
comparative FPG screening protocol fol-
lowed by an OGTT in those women
whose FPG level was 4.4–5.0 mmol/L
will fail to identify 10.1% of the GDM
population as deﬁned by the American
Diabetes Association criteria but would
require a formal OGTT in 31.1% of the
pregnant population.
In our experience, a further reduc-
tion in the number of OGTT tests can
be obtained by using a composite risk
criteria whereby women with an FPG
$5.1 mmol/L are considered as suffering
from GDM in line with the International
Association of the Diabetes and Preg-
nancy Study Groups criteria of diagnosis
(accounting for 73.9% of GDM cases and
9.8% of normal glucose tolerance [NGT]
women);womenwith anFPG#4.4mmol/L
are considered as normal (accounting for
10.1% of GDM cases, 57.7% of NGT
cases); and women with FPG values of
4.4–5.0 mmol/L are considered as suffer-
ing from GDM if they are adipose (deﬁned
as a prepregnancy BMI ,25 kg/m2 or a
third trimester BMI ,30 kg/m2) account-
ing for 5.9% of the GDM cases and 14.2%
of the NGTwomen. AnOGTTwould then
only be required in lean women whose
FPG screening test was 4.4–5.0 mmol/L
who account for only 17.6% of the pop-
ulation. This composite screening proto-
col using an FPG, maternal adiposity,
and targeted OGTT has a sensitivity
and speciﬁcity of 89.9 and 76.1%, and
positive and negative predictive values of
26.4 and 1.2%. This composite screen-
ing is similarly useful should one prefer
to adopt the International Association
of the Diabetes and Pregnancy Study
Groups criteria for diagnosis. In this sit-
uation, the protocol had a sensitivity and
speciﬁcity of 84.1 and 86.3%, and posi-
tive and negative predictive values of
68.9 and 6.3%.
It does appear therefore that in the
Mediterranean population, it is reasonable
to adopt a composite screening protocol
to identify GDMwomen, especially when
one considers that the adipose pregnant
NGT woman carried similar risks and
should receive similar lifestyle and nutri-
tional advice as the GDM woman.
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